These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33397339)

  • 1. Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors.
    Gul R; Saeed H; Saleem Z; Rasool F; Hashmi FK; Islam M; Imran I; Raza SA; Danish Z
    BMC Med Ethics; 2021 Jan; 22(1):2. PubMed ID: 33397339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health professional's exposure, attitude, and acceptance of drug promotion by industry representatives: A cross-sectional study in Ethiopia.
    Yimenu DK; Demeke CA; Kasahun AE; Siraj EA; Wendalem AY; Bazezew ZA; Atsbeha BW; Mekuria AB
    Sci Prog; 2021; 104(2):368504211029435. PubMed ID: 34191639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report: Interactions and conflicts of interests between prescribers and medical sales representatives (MSRs) regarding prescribing and drug promotion practices in Karachi, Pakistan.
    Naqvi AA; Zehra F; Khan N; Ahmad R; McGarry K
    Pak J Pharm Sci; 2019 Mar; 32(2):687-695. PubMed ID: 31081784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study.
    Siddiqui UT; Shakoor A; Kiani S; Ali F; Sharif M; Kumar A; Raza Q; Khan N; Alamzaib SM; Farid-ul-Husnain S
    BMC Med Ethics; 2014 May; 15():36. PubMed ID: 24885167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beliefs and practices of physicians in Lebanon regarding promotional gifts and interactions with pharmaceutical companies.
    Shaarani I; Hasbini J; Farhat R; Safawi N; Sleiman J; Hammoud AK; Fayad T; Khazaal D; Elkhatib O; Berjaoui H
    East Mediterr Health J; 2024 Feb; 30(2):116-124. PubMed ID: 38491897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India.
    Gupta SK; Nayak RP; Sivaranjani R
    J Pharm Bioallied Sci; 2016; 8(1):47-51. PubMed ID: 26957869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan.
    Idris KM; Mustafa AF; Yousif MA
    East Mediterr Health J; 2012 Aug; 18(8):821-6. PubMed ID: 23057370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
    Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
    BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Promotion in India Since 2000: Problems Remain.
    Lexchin J
    Int J Health Serv; 2021 Jul; 51(3):392-403. PubMed ID: 32538245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' and physicians' perception and exposure to drug promotion: A Saudi study.
    Zaki NM
    Saudi Pharm J; 2014 Dec; 22(6):528-36. PubMed ID: 25561865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pharmaceutical promotion and incentives offered by pharmaceutical companies on the prescribing pattern of medical students: a cross-sectional study from a developing nation Pakistan.
    Gillani AH; Arshad H; Umer MF; Arshed M; Khan FU; Bashir K; Xu S; Mujtaba H; Mohamed Ibrahim MI; Fang Y
    Front Med (Lausanne); 2024; 11():1334518. PubMed ID: 38846143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Views and Perceptions of Medical Representatives and Physicians about the Role of Medical Representatives and Pharmaceutical Advertisement in Saudi Arabia - A Pilot Study.
    Faqeh S; Alansari S; Althagafi A; Abdulaziz A; Alhajjaji A; Kurdi A; Allihyani M; Qashlan M; Alhotirshi R; Alhassani R; Alsurayhi S; Alshareef O; Ali M
    J Res Pharm Pract; 2022; 11(4):127-135. PubMed ID: 37969614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industrial prospects on regulatory gaps and barriers in pharmaceutical exports and their counteraction: Local experiential with global implication.
    Mubarak Z; Abbas N; Hashmi FK; Shahbaz H; Bukhari NI
    PLoS One; 2024; 19(7):e0305989. PubMed ID: 39028685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of conflict of interest in the doctor's pharmaceutical representative Relationship.
    Lajmi H; Lajmi M; Hmaied W
    Tunis Med; 2022 fevrier; 100(2):127-132. PubMed ID: 35852246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.